The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Molecular Characterization and Epidemiology of Extended-Spectrum- β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Health Care-Associated Infection in Thailand, Where the CTX-M Family Is Endemic
Open accessAbstract
Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae have rapidly spread worldwide and pose a serious threat for health care-associated (HA) infection. We conducted molecular detection and characterization of ESBL-related bla genes, including bla TEM , bla SHV , bla CTX-M , bla VEB , bla OXA , bla PER , and bla GES , among 362 isolates of ESBL-producing E. coli ( n = 235) and ESBL-producing K. pneumoniae ( n = 127) collected from patients who met the definition of HA infection at two major university hospitals in Thailand from December 2004 to May 2005. The prevalence of ESBL-producing E. coli and ESBL-producing K. pneumoniae , patient demographics and the susceptibilities of these bacteria to various antimicrobial agents were described. A total of 87.3% of isolates carried several bla genes. The prevalence of bla CTX-M was strikingly high: 99.6% for ESBL-producing E. coli (CTX-M-14, -15, -27, -40, and -55) and 99.2% for ESBL-producing K. pneumoniae (CTX-M-3, -14, -15, -27, and -55). IS Ecp1 was found in the upstream region of bla CTX-M in most isolates. Up to 77.0% and 71.7% of ESBL-producing E. coli and ESBL-producing K. pneumoniae , respectively, carried bla TEM ; all of them encoded TEM-1. ESBL-producing K. pneumoniae carried bla SHV at 87.4% (SHV-1, -2a, -11, -12, -27, -71, and -75) but only at 3.8% for ESBL-producing E. coli (SHV-11 and -12). bla genes encoding VEB-1 and OXA-10 were found in both ESBL-producing E. coli (8.5% and 8.1%, respectively) and ESBL-producing K. pneumoniae (10.2% and 11.8%, respectively). None of the isolates were positive for bla PER and bla GES . Pulsed-field gel electrophoresis analysis demonstrated that there was no major clonal relationship among these ESBL producers. This is the first study to report CTX-M-3, CTX-M-27, CTX-M-40, SHV-27, SHV-71, and SHV-75 in Thailand and to show that CTX-M ESBL is highly endemic in the country.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Knothe, H., Shah, P., Krcmery, V., Antal, M., & Mitsuhashi, S. (1983) · Infection · doi:10.1007/bf01641355 · Cited by 912
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Winokur, P. L., Cantón, R., Casellas, J., & Legakis, N. J. (2001) · Clinical Infectious Diseases · doi:10.1086/320182 · Cited by 440
Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A., & the International Klebsiella Study Group (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3554-3560.2003 · Cited by 394
Pulsed-Field Gel Electrophoresis
Kaufmann, M. E. (2003) · Molecular Bacteriology · doi:10.1385/0-89603-498-4:33 · Cited by 367
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 359
Poirel, L., Decousser, J.-W., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2938-2945.2003 · Cited by 357
Saladin, M., Cao, V. T. B., Lambert, T., Donay, J.-L., Herrmann, J.-L., Ould-Hocine, Z., Verdet, C., Delisle, F., Philippon, A., & Arlet, G. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11126.x · Cited by 348
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf240 · Cited by 284
CTX-M: changing the face of ESBLs in the UK
Livermore, D. M., & Hawkey, P. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki239 · Cited by 278
A new plasmidic cefotaximase from patients infected withSalmonella typhimurium
Bauernfeind, A., Holley, M., Jungwirth, R., Mangold, P., Röhnisch, T., Schweighart, S., Wilhelm, R., Casellas, J. M., & Goldberg, M. (1992) · Infection · doi:10.1007/bf01704610 · Cited by 191
Bert, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf069 · Cited by 180
Poirel, L., Naas, T., Le Thomas, I., Karim, A., Bingen, E., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3355-3361.2001 · Cited by 158
Distribution of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteriaceae in Vietnam
Cao, V., Lambert, T., Nhu, D. Q., Loan, H. K., Hoang, N. K., Arlet, G., & Courvalin, P. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3739-3743.2002 · Cited by 156
Hirakata, Y., Matsuda, J., Miyazaki, Y., Kamihira, S., Kawakami, S., Miyazawa, Y., Ono, Y., Nakazaki, N., Hirata, Y., Inoue, M., et al. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.04.004 · Cited by 154
Girlich, D., Poirel, L., Leelaporn, A., Karim, A., Tribuddharat, C., Fennewald, M., & Nordmann, P. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.175-182.2001 · Cited by 141
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals
Celenza, G., Pellegrini, C., Caccamo, M., Segatore, B., Amicosante, G., & Perilli, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl055 · Cited by 130
Vourli, S., Giakkoupi, P., Miriagou, V., Tzelepi, Ε., Vatopoulos, A. C., & TZOUVELEKIS, L. S. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09535.x · Cited by 107
Apisarnthanarak, A., Kiratisin, P., Saifon, P., Kitphati, R., Dejsirilert, S., & Mundy, L. M. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.05.008 · Cited by 89
Self-citationGray, K. J., Wilson, L., Phiri, A. J., CORKILL, J. E., French, N., & Hart, C. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl037 · Cited by 51
Cited by
The changing epidemiology of resistance
Hawkey, P. M., & Jones, A. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp256 · Cited by 773
Korzeniewska, E., Korzeniewska, A., & Harnisz, M. (2013) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2013.01.014 · Cited by 302
G. Deku, J., O. Duedu, K., Ativi, E., E. Kpene, G., & K. Feglo, P. (2021) · Ghana Medical Journal · doi:10.4314/gmj.v55i4.11 · Cited by 18
Metadata
- Authors
- Kiratisin, P., Apisarnthanarak, A., Laesripa, C., & Saifon, P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-08
- Volume
- 52
- Issue
- 8
- Pages
- 2818-2824
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2001838110
- Cited by
- 261
- References
- 27
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.